These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 1379912)
1. Alglucerase. A review of its therapeutic use in Gaucher's disease. Whittington R; Goa KL Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912 [TBL] [Abstract][Full Text] [Related]
2. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease]. Pérez-Calvo JI; Giraldo P; Giralt M Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260 [TBL] [Abstract][Full Text] [Related]
3. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Hollak CE; Aerts JM; Goudsmit R; Phoa SS; Ek M; van Weely S; von dem Borne AE; van Oers MH Lancet; 1995 Jun; 345(8963):1474-8. PubMed ID: 7769902 [TBL] [Abstract][Full Text] [Related]
4. Gaucher's disease: a review. Morales LE Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893 [TBL] [Abstract][Full Text] [Related]
5. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease. Whittington R; Goa KL Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294 [TBL] [Abstract][Full Text] [Related]
7. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606 [TBL] [Abstract][Full Text] [Related]
8. A less costly regimen of alglucerase to treat Gaucher's disease. Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells. Bijsterbosch MK; Donker W; van de Bilt H; van Weely S; van Berkel TJ; Aerts JM Eur J Biochem; 1996 Apr; 237(2):344-9. PubMed ID: 8647071 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic targets in Gaucher's disease]. Giraldo P; Roca M Med Clin (Barc); 2011 Sep; 137 Suppl 1():46-9. PubMed ID: 22230126 [TBL] [Abstract][Full Text] [Related]
11. Imiglucerase and its use for the treatment of Gaucher's disease. Weinreb NJ Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336 [TBL] [Abstract][Full Text] [Related]
15. First long-term results of imiglucerase therapy of type 1 Gaucher disease. Niederau C; vom Dahl S; Häussinger D Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964 [TBL] [Abstract][Full Text] [Related]
16. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Zimran A; Elstein D; Kannai R; Zevin S; Hadas-Halpern I; Levy-Lahad E; Cohen Y; Horowitz M; Abrahamov A Am J Med; 1994 Jul; 97(1):3-13. PubMed ID: 8030654 [TBL] [Abstract][Full Text] [Related]
17. Gaucher's disease in Lithuania: its diagnosis and treatment. Kleinotienė G; Tylki-Szymanska A; Czartoryska B Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991 [TBL] [Abstract][Full Text] [Related]
18. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months]. Versteegh C; Avni F; Cuvelier P; Ferster A Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741 [TBL] [Abstract][Full Text] [Related]
19. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy. Mazher W; Ali J; Abubakar S; Basar S; Murtaza G J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391 [TBL] [Abstract][Full Text] [Related]
20. Taliglucerase alfa for the treatment of Gaucher's disease. Haddley K Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]